Tumor Enhancement and Heterogeneity Are Associated With Treatment Response to Drug-Eluting Bead Chemoembolization for Hepatocellular Carcinoma
- 1 January 2017
- journal article
- abdominal imaging
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Computer Assisted Tomography
- Vol. 41 (2), 289-293
- https://doi.org/10.1097/rct.0000000000000509
Abstract
Purpose Treatment response to drug-eluting bead chemoembolization (DEB-TACE) is well established for patients with hepatocellular carcinoma (HCC); however, few studies have evaluated tumor imaging characteristics associated with treatment responses. The aim of our study was to identify imaging characteristics associated with treatment responses and overall survival after DEB-TACE of HCC. Methods This is a retrospective cohort study of 33 tumors in 32 patients who underwent DEB-TACE for inoperable HCC in a single, large academic medical center. Arterial phase computed tomography data were reviewed to assess tumor size, edge characteristics, tumor enhancement on pixel density histogram, and heterogeneity using coefficient of variation. We assessed correlation between these markers of tumor morphology and response to DEB-TACE using mRECIST criteria, progression-free survival, and overall survival. Results Tumor heterogeneity (P = 0.01) and tumor enhancement greater than 50% (P = 0.05) were significantly associated with complete response to DEB-TACE in patients with HCC; however, neither was associated with overall or progression-free survival. Tumor size and edge characteristics were not associated with complete response to DEB-TACE, although tumor size greater than 6 cm was associated with worse overall survival (hazard ratio, 3.349; P = 0.02). Conclusions Tumor heterogeneity and enhancement on arterial phase imaging may be predictive markers of treatment response to DEB-TACE among patients with HCC.Keywords
This publication has 17 references indexed in Scilit:
- Textural Parameters of Tumor Heterogeneity in 18F-FDG PET/CT for Therapy Response Assessment and Prognosis in Patients with Locally Advanced Rectal CancerJournal of Nuclear Medicine, 2014
- Fractal Analysis of Contrast-Enhanced CT Images to Predict Survival of Patients with Hepatocellular Carcinoma Treated with SunitinibDigestive Diseases and Sciences, 2014
- Establishment of a Multidisciplinary Hepatocellular Carcinoma Clinic is Associated with Improved Clinical OutcomeAnnals of Surgical Oncology, 2013
- A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancerAnnals of Oncology, 2013
- Therapeutic Delays Lead to Worse Survival Among Patients With Hepatocellular CarcinomaJournal of the National Comprehensive Cancer Network, 2013
- Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V StudyCardioVascular and Interventional Radiology, 2009
- Texture Analysis of Aggressive and Nonaggressive Lung Tumor CE CT ImagesIEEE Transactions on Biomedical Engineering, 2008
- Prognosis of hepatocellular carcinoma: Comparison of 7 staging systems in an American cohortHepatology, 2005
- Prospective validation of the CLIP score: A new prognostic system for patients with cirrhosis and hepatocellular carcinomaHepatology, 2000
- Prognosis of Hepatocellular Carcinoma: The BCLC Staging ClassificationSeminars in Liver Disease, 1999